Compare MGM Resorts International (MGM) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MGM Resorts International vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? MGM Resorts International trades at $30.56 (market cap $7.55B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: MGM Resorts International is far larger — about 3.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and MGM Resorts International pays a 0.03% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| MGM | SLS | |
|---|---|---|
Market Cap | $7.55B | $2.28B |
Volume | 5,398,410 | 3,128,960 |
Sector | Consumer Cyclical | Health |
52-Week High | $50.69 | $15.46 |
52-Week Low | $30.00 | $1.39 |
Typical Hold Time | 91 Days | — |
Enterprise Value | $34.85B | $2.15B |
Dividend Yield | 0.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MGM Resorts International (MGM) trades at $30.00, down 1.77% on the day, reflecting recent volatility following the collapse of Barry Diller's $48.30 per share acquisition proposal. The stock is technically bearish with key support at $29, while fundamentals show mixed signals: revenue growth is steady but net income margin has compressed to 2.4% in 2025. Analyst consensus remains bullish with a $48.75 price target, though near-term sentiment is pressured by deal uncertainty.
The outlook hinges on MGM's ability to stabilize earnings and potentially pursue strategic alternatives like a bid for People Inc. Upside exists if management executes on value-unlocking initiatives, but risks include integration challenges, high debt levels, and macroeconomic sensitivity. The current price offers a discount to analyst targets, presenting a contrarian opportunity amid weak sentiment.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
